Glycyl-tRNA Synthetase (GARS) (Middle Region) Peptide
Quick Overview for Glycyl-tRNA Synthetase (GARS) (Middle Region) Peptide (ABIN8101801)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- GARS Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-GARS antibody ( ARP58758_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GARS (Glycyl-tRNA Synthetase (GARS))
-
Background
-
Background Information: GARS catalyzes the attachment of glycine to tRNA(Gly). Is also able produce diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways, by direct condensation of 2 ATPs.This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative Symbols: CMT2D, DSMAV, GlyRS, HMN5, SMAD1
-
Molecular Weight
- 83kDa
-
Gene ID
- 2617
-
NCBI Accession
- NP_002038
-
UniProt
- P41250
Target
-